Êîñìåòîëîã, Äåðìàòîëîã
Ïðèåì îò 2000 1800 - 10%
Âðà÷ ïðèíèìàåò â ñëåäóþùèõ êëèíèêàõ:
Ñòîèìîñòü ïðè¸ìà â «Ìíîãîïðîôèëüíàÿ êëèíèêà Ñåñòðîðåöêàÿ»
Àäðåñ: Ïîãðàíè÷íèêîâ ä.2, ñòð. 1
Ñòîèìîñòü ïðè¸ìà â «NuAnce (Íþàíñ)»
Àäðåñ: Íåêðàñîâà 29
Ìåòðî: ×åðíûøåâñêàÿ Ïëîùàäü Âîññòàíèÿ Ìàÿêîâñêàÿ
Îáùèå ñâåäåíèÿ
Âëàäååò ìåòîäèêàìè:
- ìåçîòåðàïèÿ;
- áèîðåâèòàëèçàöèÿ;
- êîíòóðíàÿ ïëàñòèêà;
- Botox;
- ôîòîòåðàïèÿ;
- ìèêðîòîêîâàÿ òåðàïèÿ;
- RF ëèôòèíã;
- ïèëèíãè;
- óõîäîâûå.
Îáðàçîâàíèå
- Äèïëîì ïî ñïåöèàëüíîñòè "Ëå÷åáíîå äåëî", Ñàíêò-Ïåòåðáóðãñêàÿ ãîñóäàðñòâåííàÿ ïåäèàòðè÷åñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ, ëå÷åáíûé ôàêóëüòåò (2006 ã.)
- Îðäèíàòóðà ïî ñïåöèàëüíîñòè "Äåðìàòîâåíåðîëîãèÿ", Ñàíêò-Ïåòåðáóðãñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ ïîñëåäèïëîìíîãî îáðàçîâàíèÿ, êàôåäðà äåðìàòîâåíåðîëîãèè (2008 ã.)
- Àñïèðàíòóðà ïî ñïåöèàëüíîñòè "Äåðìàòîâåíåðîëîãèÿ", Ñàíêò-Ïåòåðáóðãñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ ïîñëåäèïëîìíîãî îáðàçîâàíèÿ, êàôåäðà äåðìàòîâåíåðîëîãèè (2011 ã.)
Ïîâûøåíèå êâàëèôèêàöèè
- "Äåðìàòîêîñìåòîëîãèÿ", Ñàíêò-Ïåòåðáóðãñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ ïîñëåäèïëîìíîãî îáðàçîâàíèÿ (2007 ã.)
- "Ìåçîòåðàïèÿ", Ñàíêò-Ïåòåðáóðãñêàÿ ìåäèöèíñêàÿ àêàäåìèÿ ïîñëåäèïëîìíîãî îáðàçîâàíèÿ (2008 ã.)
- "Ïðèìåíåíèå êîñìåöåâòè÷åñêèõ ñðåäñòâ Mediderma/Sesderma ïî ïîäãîòîâêå è ïðîâåäåíèþ õèìè÷åñêèõ ïèëèíãîâ è â ïîñòïèëèíãîâîì óõîäå" (2008 ã.)
- "Ìåçîòåðàïèÿ" (2008 ã.)
- "Ëèíèÿ ïðîôåññèîíàëüíîé êîñìåòèêè Holy Land" (2009 ã.)
- "Õèðîìàññàæ ëèöà" (2009 ã.)
- "Ìåòîäèêè ðàáîòû ñ èíòðàäåðìàëüíûìè èìïëàíòàöèè íà îñíîâå ãèàëóðîíîâîé êèñëîòû Juvidem Ultra, Surgiderm" (2010 ã.)
- "Ìåòîäèêè ðàáîòû ñ ïðåïàðàòîì Botox" (2010 ã.)
- "Ìåòîäèêà Ìèêðîòîêîâàÿ òåðàïèÿ" (2010 ã.)
- "Ëàçåðíûå òåõíîëîãèè â äåðìàòîâåíåðîëîãèè ñ êóðñîì äåðìàòîñêîïèè", Ïåðâûé Ñàíêò-Ïåòåðáóðãñêèé ãîñóäàðñòâåííûé ìåäèöèíñêèé óíèâåðñèòåò èìåíè àêàäåìèêà È.Ï. Ïàâëîâà (2012 ã.)
- "Òåîðèÿ è ïðàêòèêà ïðèìåíåíèÿ ïðåïàðàòà äèñïîðò â ýñòåòè÷åñêîé ìåäèöèíå" (2015 ã.)
- "Íèòåâîé ëèôòèíã Aptos" (2016 ã.)
- "Ïðîäâèíóòàÿ ìåäèöèíñêàÿ êîñìåòîëîãèÿ ëèöà òåëà" (2017 ã.)
- "Êîìïëåêñíûé ïîäõîä è íîâûå ìåòîäèêè â ýñòåòè÷åñêîé ìåäèöèíå", Ýêñïåðòíûé ôîðóì Àïòîñ (2017 ã.)
- "Ëàçåðíûå è ñâåòîâûå ìåòîäèêè â êîñìåòîëîãèè" (2017 ã.)
Ìåñòà ðàáîòû
- Âðà÷-êîñìåòîëîã, Ãðóïïà êëèíèê Äåçèð, ãîðîä Ñàíêò-Ïåòåðáóðã (2016 ã.)
- ÀÎ Ïîëèêëèíè÷åñêèé êîìïëåêñ (2017 ã.)
- Âðà÷-êîñìåòîëîã, Êëèíèêà êîñìåòîëîãèè NuAnce , ãîðîä Ñàíêò-Ïåòåðáóðã (2021 ã.)